Condensed Separate Interim Cash flows for the period ended March 31, 2021 | Β | Β | Β | Β | Β | Β | Β | Β | Notes | Mar. 31, 2021 | Β | Mar. 31, 2020 | Β | Β | Β | EGP Thousands | Β | EGP Thousands | Β | Β | Β | Β | Β | Β | Β | Cash flow from operating activities | Β | Β | Β | Β | Β | Profit before income tax | Β | 4,091,786 | Β | 3,648,456 | Β | Adjustments to reconcile net profit to net cash provided by operating activities | Β | Β | Β | Β | Β | Fixed assets depreciation | 14 | 194,609 | Β | 160,538 | Β | Impairment charge for credit losses (Loans and advances to customers and banks) | Β | 720,756 | Β | 1,272,649 | Β | Other provisions charges | 17 | 114,144 | Β | 439,410 | Β | Impairment charge for credit losses (due from banks) | Β | (4,030) | Β | 14,782 | Β | Impairment charge for credit losses (financial investments) | Β | (14,644) | Β | (47,321) | Β | Impairment charge for other assets | Β | 12,676 | Β | 13,707 | Β | Exchange revaluation differences for financial assets at fair value through OCI | Β | 23,042 | Β | 287,889 | Β | Impairment charge financial assets at fair value through OCI | Β | (72,957) | Β | 69,863 | Β | Exchange differences in financial investments in subsidiary | Β | - | Β | 719 | Β | Utilization of other provisions | 17 | (43,518) | Β | (726) | Β | Other provisions no longer used | 17 | (5,872) | Β | (38,630) | Β | Exchange differences of other provisions | 17 | (15,271) | Β | (22,219) | Β | (Profits) losses from selling property, plant and equipment | Β | (1,250) | Β | (94) | Β | (Profits) losses from selling financial investments | 12 | (420,698) | Β | (554,113) | Β | Shares based payments | Β | 162,451 | Β | 145,069 | Β | Released (Impairment) charges of investments in associates and subsidiaries | Β | - | Β | 14,100 | Β | Operating profits before changes in operating assets and liabilities | Β | 4,741,224 | Β | 5,404,079 | Β | Β | Β | Β | Β | Β | Β | Net decrease (increase) in assets and liabilities | Β | Β | Β | Β | Β | Due from banks | Β | (12,278,859) | Β | 211,025 | Β | Financial assets at fair value through P&L | 12 | 18,839 | Β | 104,116 | Β | Derivative financial instruments | Β | (66,183) | Β | 35,892 | Β | Loans and advances to banks and customers | 10 - 11 | (2,173,587) | Β | 2,428,551 | Β | Other assets | Β | (284,984) | Β | 857,769 | Β | Due to banks | 15 | (6,304,086) | Β | (1,372,684) | Β | Due to customers | 16 | 25,076,047 | Β | 5,513,465 | Β | Income tax obligations paid | Β | (29,046) | Β | (4,639,364) | Β | Other liabilities | Β | (236,449) | Β | (722,423) | Β | Net cash used in (generated from) operating activities | Β | 8,462,916 | Β | 7,820,426 | Β | Β | Β | Β | Β | Β | Β | Cash flow from investing activities | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Proceeds (payments) for investment in associates. | Β | (158,360) | Β | - | Β | Payment for purchases of property, plant, equipment and branchesΒ constructions | Β | (347,656) | Β | (319,089) | Β | Proceeds from selling property, plant and equipment | Β | 1,250 | Β | 94 | Β | Proceeds from redemption of financial assets at amortized cost | Β | 346,898 | Β | 45,639,889 | Β | Payment for purchases of financial assets at amortized cost | Β | (3,844) | Β | (44,945,839) | Β | Payment for purchases of financial assets at fair value through OCI | Β | (55,216,492) | Β | (62,050,349) | Β | Proceeds from selling financial assets at fair value through OCI | Β | 34,497,956 | Β | 54,866,521 | Β | Net cash generated from (used in) investing activities | Β | (20,880,248) | Β | (6,808,773) | Β | Β Condensed Separate Interim Cash flows for the period ended March 31, 2021 (Cont.) |
Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Mar. 31, 2021 | Β | Mar. 31, 2020 | Β | Β | Β | EGP Thousands | Β | EGP Thousands | Β | Β | Β | Β | Β | Β | Β | Cash flow from financing activities | Β | Β | Β | Β | Β | Received (Repaid) in long term loans | Β | (14,410) | Β | (91,576) | Β | Dividend paid | Β | (1,360,652) | Β | (3,370,464) | Β | Net cash generated from (used in) financing activities | Β | (1,375,062) | Β | (3,462,040) | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Net increase (decrease) in cash and cash equivalent during the period | Β | (13,792,394) | Β | (2,450,387) | Β | Beginning balance of cash and cash equivalent | Β | 75,965,247 | Β | 22,895,017 | Β | Cash and cash equivalent at the end of the period | Β | 62,172,853 | Β | 20,444,630 | Β | Β | Β | Β | Β | Β | Β | Cash and cash equivalent comprise: | Β | Β | Β | Β | Β | Cash and balances at the central bank | Β | 21,580,813 | Β | 27,169,495 | Β | Due from banks | Β | 97,088,303 | Β | 26,640,005 | Β | Treasury bills and other governmental notes | Β | 52,339,135 | Β | 29,091,960 | Β | Obligatory reserve balance with CBE | Β | (15,671,568) | Β | (22,186,285) | Β | Due from banks with maturities more than three months | Β | (40,498,431) | Β | (10,415,104) | Β | Treasury bills with maturity more than three months | Β | (52,665,399) | Β | (29,855,441) | Β | Total cash and cash equivalent | Β | 62,172,853 | Β | 20,444,630 | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β |
Β | Β | Β | Β | Β | Β | Β | Β |